An AI-scored liquid biopsy from City of Hope caught stage 1 and 2 pancreatic cancer 87% of the time in…
A year after launch, the emirate's health department says its AI patient safety platform now connects 100% of hospitals and…
Deep learning framework PRISM diagnoses liver lesions on contrast-free MRI, cutting radiologist reading time by up to two-thirds.
An AI classifier trained on eye-movement data may spot amblyopia in patients who cannot complete standard vision tests.
Japanese bio-AI startup Craif banks $33M to push its urine-based pancreatic cancer test toward US launch.
FDA clearance brings AI nodule planning and sharper navigation to J&J's Monarch lung biopsy robot.
GenBio AI launches AIDO Cell, a stateful virtual cell that predicts how DNA, RNA and proteins shape whole-cell behavior.
TCS launches an agentic AI hub that brings governed agents to clinical trials and drug safety work.
Kyowa Kirin adopts Benchling's AI R&D platform with Cognizant handling the rollout at two research parks.
KT and Seoul National University Hospital team up on a shared AI platform for public healthcare.